Background: Cholecystectomy use varies moderately across regions and countries. The purpose of this study was to evaluate the appropriateness of the use of cholecystectomy in patients with nonmalignant diseases in different hospitals using explicit criteria developed by an expert panel. Methods: Patients on waiting lists to undergo a cholecystectomy for nonmalignant diseases in six public hospitals in Spain were included in this prospective observational study over a 1-year period. Appropriateness criteria were first developed by a panel of experts using the RAND appropriateness method. The appropriateness of the indication was judged by applying explicit criteria developed previously. Complications were recorded 3 months after surgery. Results: After evaluation of 960 patients, 7 (0.7%) were considered to have undergone inappropriate procedures and 76 (7.9%) were judged to be uncertain. Differences were found in the rate of appropriateness among some centres (inappropriateness rate ranging from to 0 to 2.6%). No differences were found among the appropriateness categories for length of stay or complications, mortality, or readmission up to the third month after discharge. Conclusions: This study identified a low percentage of inappropriately performed cholecystectomies in our area. Even so, appropriateness differences among hospitals were found.
of cholecystectomy is still increasing in most developed countries, 1 ,2 but surgical rates vary moderately across regions and countries, 3 ,4 a finding not explained solely by differences in the prevalence of gallbladder disease. Variations in clinical decision making may also contribute. In relation to this, the appropriateness of use of medical procedures has been seen as an important element in quality of care. 5 Central to this investigation is the determination of what constitutes appropriate indications for a given procedure. A method that combines expert opinion with available scientific evidence was developed by investigators at the RAND Corporation and the University of California at Los Angeles. 6 This method has been used to evaluate the appropriateness of a variety of medical and surgical interventions, including cholecystectomy. Previous RAND methodology-based studies of this procedure were performed in the early 1980s in the United States, 7 and in the late 1980s in Israel 8 and the United Kingdom. 9 The goal of those studies was to provide managers and clinicians with information that would help them decide whether or not cholecystectomy was appropriate for a specific patient. Ten to 20 years have passed since those panels convened, and important changes have occurred in this field. The introduction of echography and other imaging tests has improved the diagnosis of patients with gallbladder disease or digestive symptoms. At the same time, new pharmacologic or invasive modalities, such as endoscopic retrograde cholangiopancreatography (ERCP), or surgical treatments, such as laparoscopy, have changed the indications for the intervention. Therefore, the criteria developed in the 1980s are no longer useful. In our criteria, we introduced variables such as the use of ERCP or new imaging tests such as echography not included in those previous studies. Our algorithm tried to incorporate new evidence and new scenarios to present updated explicit criteria of the indication for cholecystectomy. A new field study applying those updated criteria was found necessary. The goal of this study was to apply explicit criteria, developed using a mutidisciplinary approach, to examine the appropriateness of the indications for cholecystectomy in patients with nonmalignant diseases in various hospitals in Spain.
METHODS

Explicit criteria development
The criteria for measuring the appropriateness of the use of cholecystectomy were developed according to a previously described explicit method, 6 i.e., the RAND appropriateness method, which consists of the following steps. First, an extensive literature review was performed to summarize existing knowledge concerning efficacy, effectiveness, risks, costs, and opinions about the use of cholecystectomy to treat nonmalignant diseases. Second, from this review, a comprehensive and detailed list of mutually exclusive and clinically specific scenarios (indications) was developed in which cholecystectomy might be performed. This list contained 414 indications for cholecystectomy. Each indication was specified in sufficient detail that patients within a given indication were reasonably homogeneous. A detailed description of the variables and their categories and definitions that were considered to create the indications has been published elsewhere. 10 The ratings were confidential and took place in two rounds, using a modified Delphi process. The first round was performed before the panel meeting. The results were collated and presented to the panelists at a 1-day meeting. Each panelist received the anonymous ratings of the other panelists as well as a reminder of his own ratings. After extensive discussion, panelists revised the indications according to the definitions. During the first round, each panelist rated 390 indications, and during the second round 414 indications, because a new age category was added in some cases. Results of part of the work of the panel of experts were included in a previous publication. 10 
Data collection
This prospective observational study took place in six public hospitals (four university-affiliated and two community-based). All the hospitals belonged to the Basque Health ServiceOsakidetza, a local government agency in the Basque Country, and to the Spanish National Health Service. The identities of the hospitals and surgeons were not revealed in the research reports. Physicians in each hospital were blinded to the study goals.
The recruitment of patients on the waiting list started in March 1999 and ended in March 2000. All patients undergoing cholecystectomy, who were followed in any of the six hospitals, were included in the study. Patients with malignant, severe organic, or psychiatric diseases, were excluded. A total of 1,009 patients were placed on the waiting list during that time; nine were excluded because they had malignant diseases. Of 1,000 patients who fulfilled the selection criteria, 96.3% of the medical records were accessible and reviewed. Of the 963, three presented with immunodepression (transplant, human immunodeficiency virus) and were excluded from this study.
To collect data and determine appropriateness, we developed a computerized algorithm based on the results of our panel. We also developed data collection questionnaires that included variables before the intervention, admission, and discharge, including the intervention, and complications 3 months after discharge. Besides those variables belonging to the appropriateness algorithm, which were mentioned previously, other variables collected included sociodemographic data, height, weight, main complaint, 12 comorbidities (diabetes, hypertension, cardiac disease, dementia, depression, chronic obstructive pulmonary disease, stroke, cancer, renal disease, hepatic disease, anemia, and arthritis), previous interventions, intervention characteristics, local and general complications peri-and post-intervention, reintervention, death, and length of hospital stay. Three trainee reviewers collected the data from the medical record via a standardized questionnaire. The reviewers were blinded to the specific study goals. Three months after discharge, all medical records were again reviewed to determine if the patient had been readmitted, died, or had any complication resulting from the intervention. There were no statistically significant differences among the participating hospitals in patient age, sex, recorded comorbidities, and type of intervention. There were differences among them in the surgical risk measured by the ASA and diagnosis group (table 4) . When considering the differences among the centres, hospital 5 had the highest appropriate rate (97.1%) and the lowest uncertain-inappropriate rate (2.9%). Hospital 4 had the highest inappropriate rate (2.6%), though just on 4 patients. Hospital 6 had the highest uncertain-inappropriate rate (12.8%) and the lowest appropriate rate (87.2%). These differences were statistically significant (table 5) . Hospital 6 had an OR 4.8 higher than hospital 5, of having an uncertain-inappropriate case, which were significant differences (p<0.05). We recorded the mortality rate, complications during the intervention, admission, and length of stay at each hospital. At 3 months, we also recorded the mortality rate, complications, and readmissions resulting from the intervention. The mortality rate was 0.3%, the mean length of stay was 4 days, and 23.8% developed at least one local complication, while 10.9% presented with a systemic complication from admission until revision at 3 months. When comparing if the rates of any of these adverse outcomes differed among appropriateness groups, we did not find any statistically significant differences among appropriateness groups with respect to these adverse outcomes. A sample of 121 records was reviewed by members of the research team, for a few relevant variables, to test the accuracy of the data retrieved by the reviewers. We found Kappa correlations higher than 0.99 in all cases.
Statistical analysis
DISCUSSION
The present study assessed prospectively the appropriateness of surgical indications for patients undergoing cholecystectomy for nonmalignant diseases in a region of Spain in 1999 to 2000, using updated appropriateness criteria developed by a national panel of experts directed by this team. Applied as a screening tool for patients scheduled for surgery, those appropriateness criteria indicated a very low percentage (0.7%) of potentially inappropriate procedures, compared to other studies in which a similar methodology has been used. Of those RAND appropriateness studies done on gastroenterologic problems, inappropriateness rates ranged from 18 to 49% for the use of upper gastrointestinal endoscopy 12-14 and from 25 to 31% for colonoscopy. 15 From the previous RAND cholecystectomy panels developed in the 1980s in the United States, Israel, and United Kingdom, the explicit criteria were applied only in the Israeli and United Kingdom field studies. 5, 16 The UK study found inappropriateness rates ranging from 2 to 30% depending on which of two different sets of criteria were used to evaluate cases, one compiled by a panel of surgeons and the other a mixed panel. They concluded that those judged as inappropriate had only vague symptoms, which matched our findings. The inappropriateness rates ranged from 17 to 36% in Israel, much higher than ours. Other studies using RAND appropriateness methodology in other procedures, i.e. cardiac procedures, found a low inappropriateness rate similar to ours; one was a study in the US 17 and another in Sweden. 18 Some authors have included patients in the uncertain category with the inappropriate cases, 19,20 a group that was called lessthan-appropriate. We did so in part because we found very few inappropriate cases and also because for logistic regression analysis either a dichotomous dependent variable is needed or, if more categories are included, ordinal categorical variables are preferred. Because we could not assume the latter for the three appropriateness categories, we chose the first option comparing appropriate versus less-than-appropriate categories. The percentage of indications considered uncertain in this study was fairly low compared to other RAND studies. Just those mentioned previously, where the inappropriateness rate was similar, had a low uncertain rate as well. 17, 18 Nevertheless, these results indicate that there were still 7.9% of cases for which the panelists could not judge the appropriateness of the indication. Therefore, it would be adequate to study the risk-benefit ratio of performing a cholecystectomy on these patients, which, in our case, were exclusively asymptomatic cholelithiasis with low surgical risk, and one patient with high surgical risk.
Indications that were more likely to be considered inappropriate were those in which the surgical risk was high (ASA IV), the patients were older than 75 years, or the patient was diagnosed with asymptomatic cholelithiasis. This is because our criteria did not consider the intervention appropriate in patients with a high surgical risk (either because of age or ASA) or in those with asymptomatic gallstones. Some surgical interventions with outstanding patient benefits, i.e. hip prosthesis for patients with hip ostearthritis, are performed regardless of ASA stage or age. 21 However, with cholecystectomy even previous studies showed that the panel criteria were highly correlated with the degree of comorbidity of patients, and their conclusions were similar to ours. 22 Finally, asymptomatic cholelithiasis has not been considered an indication for prophylactic cholecystectomy In any case, besides the low rate of inappropriateness, we found some differences among our hospitals in the rate of appropriateness. Hospital 5 or 2, which have the lowest inappropriateness rate, seems to match the panel criteria in all diagnosis groups, even though no member of the panel belongs to those centres nor were surgeons of that centres aware of the study goals. Limitations related to the work of the panel were described in a previous study. 10 Additionally, data collection presented some limitations. The three blinded reviewers were physicians trained to assess and record the main variables of the algorithm in a standardized manner to reduce the chances of bias. We checked during their training for their reliability with good results, and about their accuracy by checking some variables with excellent correlations. However, the quality of the data of some important variables necessary for the appropriateness algorithm can be questionable when depending exclusively on the medical record. In our case, most relevant variables (age, surgical risk, diagnosis, comorbidities) were properly recorded. Laparoscopy is a surgical option that has rapidly increased in the last few years. In this study, we did not evaluate the appropriateness of the different surgical options currently available, such as open cholecystectomy vs. laparoscopy, which could be the subject of another panel to create explicit criteria for those specific surgical techniques, and, later, another field study. Even so, it was inevitable that panelists were thinking of laparoscopy as the first surgical option. Also, our results showed that in appropriate indications laparoscopy was more likely to be used, mainly because those were patients with lower surgical risk. This study was performed in six public hospitals in the Spanish health care system, a public, universal coverage system. The generalizability of our results to other different health care systems is questionable though it is quite likely that results in other Spanish public centres are the same.
In conclusion, this prospective observational study demonstrates that the rate of inappropriate-uncertain cholecystectomies in our public hospitals, though low, showed variations in appropriateness among centres. Surgery was more likely to be considered inappropriate in patients with asymptomatic cholelithiasis, or high surgical risk, which matches current state-of-the-art criteria about the indication of cholecystectomy for patients with gallbladder disease. Even so, as suggested by the authors of the RAND appropriateness method, 28 if appropriateness is to be improved it must be assessed at the level of each patient, hospital, and physician.
